Lemtofit has launched the affordable Lem 3 smartwatch for the global market. The new Lemtofit Lem 3 smartwatch is said to have received the China Food and Drug Administration (CFDA) certification for its ECG function. This means that the smartwatch can be used as an ECG tool.
The Lem 3 is a relatively affordable
wearable that was recently announced by Lemtofit. It comes with a bouquet of
health monitoring features seemingly signposted by its ECG functionality. Other
health tracking features present in the Lem 3 are blood glucose (non-invasive),
blood oxygen, heart rate, and body temperature monitoring.
The smartwatch packs a 1.92-inch display,
supports Bluetooth calling and various sports modes are available to the user.
The smartwatch can also be controlled using its voice assistant. The watch has
up to 7 days of runtime on a single charge and typical usage.
Although Lemtofit has stated that the Lem
3 has the CFDA certification for its ECG measuring tool, it has yet to state
the details of the certification. This implies that the accuracy of ECG
measurements by the smartwatch has not been established. The Lem 3 will also
need to be certified by the National Medical Product Administration (NMPA),
which replaced the CFDA in 2018. Non-invasive blood glucose measurements are
seen as unreliable, as the US Food and Drug Administration (FDA) released a
statement that advised against using smartwatches and smart rings to take blood
glucose measurements.
The Lem 3 has a retail price of US$ 159.99
but can be purchased directly from Lemtofit at a discounted price of US$ 49.99.
The impressive collection of health and fitness features present in the
smartwatch, coupled with its very cheap price, could spur demand for the Lem 3.
